Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $71.3bn in 2020, representing a compound annual growth rate (CAGR) of 5.6% between 2016 and 2020.
- An ageing population in Germany, with a quarter of the population estimated to be over the age of 65 by 2050, is likely to drive demand for pharmaceutical products.
- Innovation in the German pharmaceutical market is likely to be supported by the launch of the Future Fund by the federal government in 2021. This could prove to be a lucrative opportunity for smaller biotechnology and pharmaceutical firms to expand, contributing to overall growth in the market in the long-term.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Germany pharmaceuticals market by value in 2020?
- What will be the size of the Germany pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent strategic partnerships?
7.5. Are there any threats towards leading players?
8 Company Profiles
8.1. Novartis AG
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. Boehringer Ingelheim GmbH
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany pharmaceuticals market value: $ billion, 2016-20
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Germany pharmaceuticals market share: % share, by value, 2020
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Boehringer Ingelheim GmbH: key facts
Table 17: Boehringer Ingelheim GmbH: Key Employees
Table 18: Germany size of population (million), 2016-20
Table 19: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 20: Germany gdp (current prices, $ billion), 2016-20
Table 21: Germany inflation, 2016-20
Table 22: Germany consumer price index (absolute), 2016-20
Table 23: Germany exchange rate, 2016-20
List of Figures
Figure 1: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 10: Germany pharmaceuticals market share: % share, by value, 2020
